Martyna Ścibiorek

Akces NCBR

About Presenter

Dr Martyna Ścibiorek is a biotechnology leader and acceleration expert working at the intersection of deep-tech, research commercialization, and international innovation ecosystems. At Akces NCBR, she drives the development of high-risk, early-stage R&D ventures, building continuity pathways that strengthen Poland’s deep-tech landscape. Her experience spans Europe, Africa, and the Middle East, where she has led large-scale skills programs, supported biotech startups, and built cross-continental partnerships with industry, investors, and research institutions. Previously a Business Development Manager for Europe at Nawah Scientific and a Skills Development Manager at UVU Bio, she is known for advancing science-driven entrepreneurship and designing acceleration models that help early innovators move from concept to market impact.

Title of presentation
Daring to Win – How Akces NCBR Fuels High-Risk, High-Impact Startups
Focus Areas

StartUp & ScaleUp Zone: Where Life Science Ventures Take Off

Objective: Pitch, partner and grow – connect with investors, corporates and mentors to accelerate your journey.

Introduction: the Problem

Akces NCBR operates within the NCBR Group as an independent unit created to address a critical gap in the Polish innovation ecosystem: the lack of systemic support for high-risk, deep-tech startups at the earliest stages of development. Many breakthrough technologies fail in the so-called “valley of death” due to insufficient funding, lack of commercialization support, and fragmented pathways between R&D and the market. This challenge is particularly visible in projects with low Technology Readiness Levels (TRL), where technological potential is high, but uncertainty, risk, and development costs prevent traditional investors or institutions from engaging.

Collaboration Offer

Akces NCBR invites partners, investors, industry experts, and ecosystem builders to join us in shaping a unified, risk-tolerant pathway for Poland’s most ambitious early-stage innovations. To address the critical “valley of death,” we are building a system in which no high-potential technology is lost due to lack of continuity, fragmented support, or isolated interventions. To make this possible, we seek collaboration with organizations that can strengthen project validation, market access, technical expertise, and investment readiness at key development milestones.